Entocort EC, a new ORAL form of budesonide for Crohn's disease
November 2001
AstraZeneca will soon introduce Entocort EC, a new ORAL form of budesonide for Crohn's disease.
It's approved for acute flare-ups that involve the ileum and/or ascending colon...it's not approved for chronic use.
Entocort EC releases budesonide in the small intestine and colon to decrease inflammation.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote